definiens: shall mean the costs other than Stressgen RRP Devel opment Costs, arising from Development Activities undertaken by S tressgen or on its behalf and incurred by Stressgen for ( a ) CMC activities related to Process B ( as defined in Article 9 ) and performed on or after [ * * * ] as the contract manufacturer of clinical supplies of Target Product, but for the period defined between the Execution Date and [ * * * ] only to the extent such costs do not exceed [ * * * ], ( b ) TC1 studies in support of transitioni ng from Process A to Process B ( as defined in Article 9 ), b ut only to the extent such costs are for activities performed on or after [ * * * ] and do not exceed [ * * * ] and ( c ) any other Development Activities performed by Stres sgen ( other than for RRP ) on or after [ * * * ] at the req uest of the JDC